RAS突变-话题@MedSci

#RAS突变#

56篇内容 | 1903人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1585300, encodeId=7fdf158530010, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=Br J Dermatol：后天性黑素细胞痣的BRAF和NRAS突变, objectType=article, longId=111592, objectId=e562111592de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e562111592de, replyNumber=0, likeNumber=82, createdTime=2017-09-02, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e562111592de, moduleTitle=Br J Dermatol：后天性黑素细胞痣的BRAF和NRAS突变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e562111592de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585299, encodeId=cc261585299c0, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=CLIN CANCER RES：NRAS突变结直肠癌患者临床特征及结局, objectType=article, longId=111132, objectId=0c48111132a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c48111132a1, replyNumber=0, likeNumber=85, createdTime=2017-08-30, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c48111132a1, moduleTitle=CLIN CANCER RES：NRAS突变结直肠癌患者临床特征及结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c48111132a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585298, encodeId=09da15852985c, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=Sci Rep：不同类型胰腺癌细胞中KRAS突变的异质性, objectType=article, longId=110587, objectId=940911058e28, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=940911058e28, replyNumber=0, likeNumber=59, createdTime=2017-08-24, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=940911058e28, moduleTitle=Sci Rep：不同类型胰腺癌细胞中KRAS突变的异质性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=940911058e28)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585297, encodeId=f998158529ea5, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=Br J Dermatol：后天性黑素细胞痣的BRAF和NRAS突变提示MAPK信号通路的激活, objectType=article, longId=106540, objectId=37c5106540e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37c5106540e8, replyNumber=0, likeNumber=70, createdTime=2017-07-26, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37c5106540e8, moduleTitle=Br J Dermatol：后天性黑素细胞痣的BRAF和NRAS突变提示MAPK信号通路的激活, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37c5106540e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585296, encodeId=df911585296ab, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=Ann Oncol：血液和肿瘤组织的RAS突变检测方法用于指导mCRC抗EGFR治疗的一致性, objectType=article, longId=105800, objectId=603c10580098, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=603c10580098, replyNumber=0, likeNumber=55, createdTime=2017-07-19, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=603c10580098, moduleTitle=Ann Oncol：血液和肿瘤组织的RAS突变检测方法用于指导mCRC抗EGFR治疗的一致性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=603c10580098)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585295, encodeId=1dd4158529570, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=CLIN CANCER RES：肺癌TP53及KRAS突变预测阻断PD-1免疫治疗反应, objectType=article, longId=104354, objectId=cb2b10435459, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb2b10435459, replyNumber=0, likeNumber=56, createdTime=2017-07-04, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb2b10435459, moduleTitle=CLIN CANCER RES：肺癌TP53及KRAS突变预测阻断PD-1免疫治疗反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb2b10435459)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585294, encodeId=b8bb158529409, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=Sci Transl Med：如何降低RAS突变型癌症的治疗负担, objectType=article, longId=100856, objectId=8ea210085625, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ea210085625, replyNumber=0, likeNumber=58, createdTime=2017-06-07, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ea210085625, moduleTitle=Sci Transl Med：如何降低RAS突变型癌症的治疗负担, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ea210085625)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585293, encodeId=494c1585293ec, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=NEJM：K-ras突变治疗获得突破，癌症治疗可能向前迈一大步, objectType=article, longId=85292, objectId=d83f85292bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d83f85292bc, replyNumber=0, likeNumber=65, createdTime=2016-12-25, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d83f85292bc, moduleTitle=NEJM：K-ras突变治疗获得突破，癌症治疗可能向前迈一大步, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d83f85292bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585292, encodeId=061015852928a, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=确定了，并非所有RAS突变都＝甲状腺癌！, objectType=article, longId=70469, objectId=a710e0469d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a710e0469d8, replyNumber=0, likeNumber=68, createdTime=2016-06-12, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a710e0469d8, moduleTitle=确定了，并非所有RAS突变都＝甲状腺癌！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a710e0469d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585291, encodeId=83de1585291e4, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=Ann Oncol：MEK抑制剂trametinib对KRAS突变的非小细胞肺癌的II期临床研究, objectType=article, longId=47689, objectId=936f4e689f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=936f4e689f6, replyNumber=0, likeNumber=66, createdTime=2015-03-05, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=936f4e689f6, moduleTitle=Ann Oncol：MEK抑制剂trametinib对KRAS突变的非小细胞肺癌的II期临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=936f4e689f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585290, encodeId=98d01585290d9, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=JCO：结直肠癌患者FOLFIRI+爱必妥的应用以及RAS突变状态的研究, objectType=article, longId=46640, objectId=739746640f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=739746640f3, replyNumber=0, likeNumber=79, createdTime=2015-02-06, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=739746640f3, moduleTitle=JCO：结直肠癌患者FOLFIRI+爱必妥的应用以及RAS突变状态的研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=739746640f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585289, encodeId=27b0158528995, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=Nature：靶向K-ras突变的小分子化合物研发成功攻克30年挑战, objectType=article, longId=26936, objectId=07352693681, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07352693681, replyNumber=0, likeNumber=66, createdTime=2013-11-24, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07352693681, moduleTitle=Nature：靶向K-ras突变的小分子化合物研发成功攻克30年挑战, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07352693681)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585288, encodeId=2ac4158528826, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=威罗菲尼治疗RAS突变型白血病, objectType=article, longId=13047, objectId=d0451304e39, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0451304e39, replyNumber=0, likeNumber=67, createdTime=2012-12-16, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0451304e39, moduleTitle=威罗菲尼治疗RAS突变型白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d0451304e39)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585287, encodeId=3225158528e4f, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=Cancer：基因KRAS突变与晚期肺腺癌患者更短存活相关联, objectType=article, longId=8408, objectId=3968840823, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3968840823, replyNumber=0, likeNumber=72, createdTime=2012-08-02, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3968840823, moduleTitle=Cancer：基因KRAS突变与晚期肺腺癌患者更短存活相关联, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3968840823)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585286, encodeId=3dfb15852861a, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=Br J Cancer: HRMA识别KRAS突变优于直接测序, objectType=article, longId=8095, objectId=85ef80953c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85ef80953c, replyNumber=0, likeNumber=66, createdTime=2012-07-25, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85ef80953c, moduleTitle=Br J Cancer: HRMA识别KRAS突变优于直接测序, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85ef80953c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585285, encodeId=9bba1585285b7, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=美批准确定癌症患者KRAS突变的新检测法, objectType=article, longId=7726, objectId=8163e726a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8163e726a0, replyNumber=0, likeNumber=90, createdTime=2012-07-11, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8163e726a0, moduleTitle=美批准确定癌症患者KRAS突变的新检测法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8163e726a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585284, encodeId=61b8158528490, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=Nature：K-RAS突变可能是癌症对靶向治疗耐药、复发根源, objectType=article, longId=7134, objectId=cef1e1342b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cef1e1342b, replyNumber=0, likeNumber=85, createdTime=2012-06-19, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cef1e1342b, moduleTitle=Nature：K-RAS突变可能是癌症对靶向治疗耐药、复发根源, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cef1e1342b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585283, encodeId=39c2158528351, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=Plos One：季红斌等揭示K-ras突变体对肺癌发生及存活的作用, objectType=article, longId=6693, objectId=ef276693e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef276693e0, replyNumber=0, likeNumber=70, createdTime=2012-05-31, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef276693e0, moduleTitle=Plos One：季红斌等揭示K-ras突变体对肺癌发生及存活的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef276693e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

RAS突变

2020-05-29

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

Br J Dermatol：后天性黑素细胞痣的BRAF和NRAS突变

2017-09-02

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

CLIN CANCER RES：NRAS突变结直肠癌患者临床特征及结局

2017-08-30

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

Sci Rep：不同类型胰腺癌细胞中KRAS突变的异质性

2017-08-24

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

Br J Dermatol：后天性黑素细胞痣的BRAF和NRAS突变提示MAPK信号通路的激活

2017-07-26

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

Ann Oncol：血液和肿瘤组织的RAS突变检测方法用于指导mCRC抗EGFR治疗的一致性

2017-07-19

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

CLIN CANCER RES：肺癌TP53及KRAS突变预测阻断PD-1免疫治疗反应

2017-07-04

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

Sci Transl Med：如何降低RAS突变型癌症的治疗负担

2017-06-07

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

NEJM：K-ras突变治疗获得突破，癌症治疗可能向前迈一大步

2016-12-25

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

确定了，并非所有RAS突变都＝甲状腺癌！

2016-06-12

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

Ann Oncol：MEK抑制剂trametinib对KRAS突变的非小细胞肺癌的II期临床研究

2015-03-05

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

JCO：结直肠癌患者FOLFIRI+爱必妥的应用以及RAS突变状态的研究

2015-02-06

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

Nature：靶向K-ras突变的小分子化合物研发成功攻克30年挑战

2013-11-24

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

威罗菲尼治疗RAS突变型白血病

2012-12-16

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

Cancer：基因KRAS突变与晚期肺腺癌患者更短存活相关联

2012-08-02

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

Br J Cancer: HRMA识别KRAS突变优于直接测序

2012-07-25

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

美批准确定癌症患者KRAS突变的新检测法

2012-07-11

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

Nature：K-RAS突变可能是癌症对靶向治疗耐药、复发根源

2012-06-19

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

Plos One：季红斌等揭示K-ras突变体对肺癌发生及存活的作用

2012-05-31

科室
- - 订阅+
  - 更多科室
工具
服务